StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.9 % BTX stock opened at $2.48 on Friday. The business’s 50-day simple moving average is $3.18. The company has a market capitalization of […]